We are live on
!
Find out more
NTC
North Tide Capital Portfolio holdings
AUM
$469M
1-Year Est. Return
6.57%
This Fund
S&P 500
This Quarter
Est. Return
+14.18%
1 Year Est. Return
+6.57%
3 Year Est. Return
+14.81%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$449M
AUM Growth
-$201M
(-31%)
Cap. Flow
-$255M
Cap. Flow
% of AUM
-56.79%
Top 10 Holdings %
Top 10 Hldgs %
96.83%
Holding
17
New
1
Increased
–
Reduced
6
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$22.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ELOS
Syneron Medical Ltd
ELOS
|
+$31.6M |
| 2 |
IPXL
Impax Laboratories, Inc.
IPXL
|
+$29.5M |
| 3 |
Perrigo
PRGO
|
+$21.5M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$17.6M |
| 5 |
Tenet Healthcare
THC
|
+$17.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 89.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TVTY
1
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $99.6M | 22.17% |
2,500,000
| – | – |
|
|
SEM
2
DELISTED
Select Medical
SEM
| $76.8M | 17.08% |
9,280,000
-1,299,200
| -12% | -$9.75M |
|
3
Gilead Sciences
GILD
$167B
| $70.8M | 15.75% |
1,000,000
| – | – |
|
4
Viatris
VTRS
$20.1B
| $38.8M | 8.64% |
1,000,000
| – | – |
|
|
ENDP
5
DELISTED
Endo International plc
ENDP
| $33.5M | 7.46% |
3,000,000
-1,500,000
| -33% | -$17.6M |
|
|
SVU
6
DELISTED
SUPERVALU Inc.
SVU
| $32.9M | 7.32% |
1,428,571
| – | – |
|
|
7
McKesson
MCK
$98.5B
| $24.7M | 5.49% |
+150,000
| New | +$22.7M |
|
|
8
Perrigo
PRGO
$1.48B
| $22.7M | 5.04% |
300,000
-300,000
| -50% | -$21.5M |
|
|
9
Tenet Healthcare
THC
$16.8B
| $19.3M | 4.3% |
1,000,000
-1,000,000
| -50% | -$17.4M |
|
|
IPXL
10
DELISTED
Impax Laboratories, Inc.
IPXL
| $16.1M | 3.58% |
1,000,000
-2,000,000
| -67% | -$29.5M |
|
11
Option Care Health
OPCH
$3.41B
| $8.14M | 1.81% |
750,000
| – | – |
|
|
VVUS
12
DELISTED
Vivus Inc
VVUS
| $6.1M | 1.36% |
500,000
-400,930
| -45% | -$4.4M |
|
13
Accuray
ARAY
$30.8M
| – | – |
-154,500
| Closed | -$734K |
|
14
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$41.4B
| – | – |
-1,700,000
| Closed | -$126M |
|
|
QHC
15
DELISTED
Quorum Health Corporation
QHC
| – | – |
-1,590,200
| Closed | -$8.65M |
|
|
HZNP
16
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| – | – |
-692,700
| Closed | -$10.2M |
|
|
ELOS
17
DELISTED
Syneron Medical Ltd
ELOS
| – | – |
-3,000,000
| Closed | -$31.6M |
|
Similar funds
SD
DG
NBC
JWM
JPCCM
MCL
GIIO
FC
North Tide Capital's Q2 2017 Portfolio in Review
As of Q2 2017, North Tide Capital held 17 positions worth $449M, down 31% from $651M the previous quarter. Its ten largest holdings account for 97% of the portfolio.
North Tide Capital withdrew a net $255M in Q2 2017, closing 5 positions and reducing 6 holdings. Its most notable exit was Syneron Medical Ltd, an estimated $31.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 64% a quarter earlier.
Against the trend, North Tide Capital opened a new position in McKesson worth $24.7M.
- North Tide Capital's largest Q2 2017 buy was McKesson: 150,000 shares worth $24.7M.
- North Tide Capital's biggest Q2 2017 reduction was Impax Laboratories, Inc., cutting an estimated $29.5M.
- North Tide Capital fully exited Syneron Medical Ltd in Q2 2017, selling an estimated $31.6M.
- North Tide Capital's ten largest holdings make up 97% of its $449M portfolio in Q2 2017.
- North Tide Capital opened 1 new position and closed 5 in Q2 2017.
- North Tide Capital's portfolio value fell 31% quarter-over-quarter to $449M.
Based on North Tide Capital's 13F filing for Q2 2017, filed 14 Aug 2017.